Cite
HARVARD Citation
Johnston, J. et al. (n.d.). PWE-028 Significantly Improved Abdominal Pain (AP) with Linaclotide (LIN) vs Placebo (PBO) in Patients (PTS) with Irritable Bowel Syndrome (IBS) Regardless of Baseline Pain Severity in 2 Phase 3 Trials. Gut. pp. A141-A142. [Online].